Shorter radiation after chemotherapy for early breast cancer
Part of Cancer, Skin clinical trials.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older.
- You have early-stage breast cancer (stages 1–3) that has not spread to lymph nodes.
- You have had breast-conserving surgery (lumpectomy) and your cancer is high-risk based on genetic testing.
- You must have received or will receive chemotherapy (before or after surgery).
- You have not had radiation to the chest or breast before.
- You do not have breast reconstruction with an implant or expander.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.